November 7, 2018 to November 11, 2018

Session 2 -
November 8, 2018, 11:20 - 12:05: Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells, Eric Vivier

Visit the Chinese Society for Immunology website